Skip to content

Clinical effect evaluation and Mechanism Study on treatment of adenoid hypertrophy with manipulation of

Clinical effect evaluation and Mechanism Study on treatment of adenoid hypertrophy with manipulation of

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064221
Enrollment
Unknown
Registered
2022-09-30
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid hypertrophy

Interventions

Test group:Massage technique of "supporting healthy and dispelling evil"

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine for adenoid hypertrophy; 2. Conform to the syndrome differentiation standard of adenoid hypertrophy in traditional Chinese medicine; 3. Patients aged from 3 to 12 years old; 4. Those who agree not to accept other relevant treatment methods during treatment; 5. Patients who have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. It is confirmed by examination that those who snore and breathe with their mouths open simply due to tonsil hypertrophy, nasal septum deflection, nasal polyps, sinusitis and nasal injury. 2. Those under 3 years old or over 12 years old. 3. Infectious disease, mental illness. 4. Those who do not meet the inclusion criteria, cannot judge the efficacy or incomplete data, etc., which affect the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Total score of nasal congestion and quality of life;

Countries

China

Contacts

Public ContactSaina Wang

Longhua Hospital Shanghai University of Traditional Chinese Medicine

saina1234@126.com+86 13671707046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026